nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ABCG2—Glyburide—gestational diabetes	0.255	0.324	CbGbCtD
Gefitinib—ALB—Glyburide—gestational diabetes	0.176	0.224	CbGbCtD
Gefitinib—CYP2C19—Glyburide—gestational diabetes	0.114	0.145	CbGbCtD
Gefitinib—CYP2C9—Glyburide—gestational diabetes	0.0948	0.12	CbGbCtD
Gefitinib—ABCB1—Glyburide—gestational diabetes	0.092	0.117	CbGbCtD
Gefitinib—CYP3A4—Glyburide—gestational diabetes	0.0551	0.07	CbGbCtD
Gefitinib—CHEK2—adipose tissue—gestational diabetes	0.00538	0.039	CbGeAlD
Gefitinib—CSNK1E—islet of Langerhans—gestational diabetes	0.00535	0.0388	CbGeAlD
Gefitinib—IRAK4—islet of Langerhans—gestational diabetes	0.00527	0.0382	CbGeAlD
Gefitinib—ERBB3—embryo—gestational diabetes	0.00499	0.0362	CbGeAlD
Gefitinib—MKNK2—islet of Langerhans—gestational diabetes	0.00491	0.0356	CbGeAlD
Gefitinib—IRAK1—islet of Langerhans—gestational diabetes	0.00491	0.0356	CbGeAlD
Gefitinib—SBK1—head—gestational diabetes	0.00475	0.0344	CbGeAlD
Gefitinib—CHEK2—vagina—gestational diabetes	0.00447	0.0324	CbGeAlD
Gefitinib—EPHA6—head—gestational diabetes	0.00371	0.0269	CbGeAlD
Gefitinib—EGFR—uterus—gestational diabetes	0.00363	0.0263	CbGeAlD
Gefitinib—EGFR—adipose tissue—gestational diabetes	0.00355	0.0257	CbGeAlD
Gefitinib—CSNK1E—uterus—gestational diabetes	0.00349	0.0253	CbGeAlD
Gefitinib—CSNK1E—adipose tissue—gestational diabetes	0.00341	0.0247	CbGeAlD
Gefitinib—MAP3K19—head—gestational diabetes	0.00337	0.0244	CbGeAlD
Gefitinib—ERBB3—uterus—gestational diabetes	0.00337	0.0244	CbGeAlD
Gefitinib—IRAK4—adipose tissue—gestational diabetes	0.00336	0.0243	CbGeAlD
Gefitinib—ERBB3—adipose tissue—gestational diabetes	0.00329	0.0239	CbGeAlD
Gefitinib—MKNK2—uterus—gestational diabetes	0.0032	0.0232	CbGeAlD
Gefitinib—MKNK2—adipose tissue—gestational diabetes	0.00313	0.0227	CbGeAlD
Gefitinib—IRAK1—adipose tissue—gestational diabetes	0.00313	0.0227	CbGeAlD
Gefitinib—MKNK1—adipose tissue—gestational diabetes	0.00309	0.0224	CbGeAlD
Gefitinib—CSNK1E—vagina—gestational diabetes	0.00284	0.0206	CbGeAlD
Gefitinib—IRAK4—vagina—gestational diabetes	0.00279	0.0202	CbGeAlD
Gefitinib—CSNK1E—head—gestational diabetes	0.00262	0.019	CbGeAlD
Gefitinib—STK10—uterus—gestational diabetes	0.0026	0.0189	CbGeAlD
Gefitinib—MKNK2—vagina—gestational diabetes	0.0026	0.0189	CbGeAlD
Gefitinib—IRAK4—head—gestational diabetes	0.00258	0.0187	CbGeAlD
Gefitinib—MKNK1—vagina—gestational diabetes	0.00257	0.0186	CbGeAlD
Gefitinib—Eruption—Glyburide—gestational diabetes	0.00255	0.137	CcSEcCtD
Gefitinib—STK10—adipose tissue—gestational diabetes	0.00255	0.0185	CbGeAlD
Gefitinib—ERBB3—head—gestational diabetes	0.00253	0.0183	CbGeAlD
Gefitinib—MKNK2—head—gestational diabetes	0.0024	0.0174	CbGeAlD
Gefitinib—MKNK1—head—gestational diabetes	0.00237	0.0172	CbGeAlD
Gefitinib—MAP2K5—adipose tissue—gestational diabetes	0.00227	0.0165	CbGeAlD
Gefitinib—STK10—vagina—gestational diabetes	0.00212	0.0153	CbGeAlD
Gefitinib—STK10—head—gestational diabetes	0.00196	0.0142	CbGeAlD
Gefitinib—MAP2K5—vagina—gestational diabetes	0.00189	0.0137	CbGeAlD
Gefitinib—MAP2K5—head—gestational diabetes	0.00175	0.0127	CbGeAlD
Gefitinib—CYP3A5—islet of Langerhans—gestational diabetes	0.00161	0.0117	CbGeAlD
Gefitinib—Hepatic failure—Glyburide—gestational diabetes	0.00127	0.068	CcSEcCtD
Gefitinib—Dermatitis bullous—Glyburide—gestational diabetes	0.00119	0.0639	CcSEcCtD
Gefitinib—ABCG2—uterus—gestational diabetes	0.00113	0.0082	CbGeAlD
Gefitinib—ABCG2—adipose tissue—gestational diabetes	0.00111	0.00802	CbGeAlD
Gefitinib—CYP2C19—vagina—gestational diabetes	0.00108	0.00785	CbGeAlD
Gefitinib—CYP1A1—uterus—gestational diabetes	0.00107	0.00778	CbGeAlD
Gefitinib—CYP1A1—adipose tissue—gestational diabetes	0.00105	0.00761	CbGeAlD
Gefitinib—CYP3A5—adipose tissue—gestational diabetes	0.00103	0.00744	CbGeAlD
Gefitinib—Pancreatitis—Glyburide—gestational diabetes	0.000965	0.0518	CcSEcCtD
Gefitinib—ABCG2—vagina—gestational diabetes	0.00092	0.00666	CbGeAlD
Gefitinib—CYP1A1—vagina—gestational diabetes	0.000873	0.00633	CbGeAlD
Gefitinib—ABCB1—islet of Langerhans—gestational diabetes	0.000855	0.0062	CbGeAlD
Gefitinib—CYP3A5—vagina—gestational diabetes	0.000854	0.00619	CbGeAlD
Gefitinib—ABCB1—embryo—gestational diabetes	0.000827	0.00599	CbGeAlD
Gefitinib—CYP1A1—head—gestational diabetes	0.000806	0.00584	CbGeAlD
Gefitinib—Hepatitis—Glyburide—gestational diabetes	0.000788	0.0423	CcSEcCtD
Gefitinib—Eye disorder—Glyburide—gestational diabetes	0.000736	0.0395	CcSEcCtD
Gefitinib—Alopecia—Glyburide—gestational diabetes	0.000696	0.0373	CcSEcCtD
Gefitinib—Malnutrition—Glyburide—gestational diabetes	0.000686	0.0368	CcSEcCtD
Gefitinib—Anaemia—Glyburide—gestational diabetes	0.000634	0.034	CcSEcCtD
Gefitinib—Angioedema—Glyburide—gestational diabetes	0.000627	0.0336	CcSEcCtD
Gefitinib—CYP2D6—head—gestational diabetes	0.000582	0.00422	CbGeAlD
Gefitinib—ABCB1—uterus—gestational diabetes	0.000558	0.00404	CbGeAlD
Gefitinib—Shock—Glyburide—gestational diabetes	0.000551	0.0295	CcSEcCtD
Gefitinib—Nervous system disorder—Glyburide—gestational diabetes	0.000549	0.0294	CcSEcCtD
Gefitinib—Thrombocytopenia—Glyburide—gestational diabetes	0.000548	0.0294	CcSEcCtD
Gefitinib—ABCB1—adipose tissue—gestational diabetes	0.000545	0.00395	CbGeAlD
Gefitinib—Anorexia—Glyburide—gestational diabetes	0.000533	0.0286	CcSEcCtD
Gefitinib—Hypotension—Glyburide—gestational diabetes	0.000523	0.0281	CcSEcCtD
Gefitinib—Dyspnoea—Glyburide—gestational diabetes	0.000499	0.0268	CcSEcCtD
Gefitinib—Decreased appetite—Glyburide—gestational diabetes	0.000487	0.0261	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000483	0.0259	CcSEcCtD
Gefitinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000458	0.0245	CcSEcCtD
Gefitinib—ABCB1—vagina—gestational diabetes	0.000453	0.00329	CbGeAlD
Gefitinib—Urticaria—Glyburide—gestational diabetes	0.000445	0.0238	CcSEcCtD
Gefitinib—Abdominal pain—Glyburide—gestational diabetes	0.000442	0.0237	CcSEcCtD
Gefitinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—FGF2—gestational diabetes	0.000422	0.00743	CbGpPWpGaD
Gefitinib—ABCB1—head—gestational diabetes	0.000419	0.00304	CbGeAlD
Gefitinib—Hypersensitivity—Glyburide—gestational diabetes	0.000412	0.0221	CcSEcCtD
Gefitinib—MKNK1—Signaling by FGFR—FGF2—gestational diabetes	0.000406	0.00715	CbGpPWpGaD
Gefitinib—Asthenia—Glyburide—gestational diabetes	0.000402	0.0215	CcSEcCtD
Gefitinib—ERBB3—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.000399	0.00703	CbGpPWpGaD
Gefitinib—Pruritus—Glyburide—gestational diabetes	0.000396	0.0212	CcSEcCtD
Gefitinib—EGFR—Androgen receptor signaling pathway—AR—gestational diabetes	0.000396	0.00697	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—GCK—gestational diabetes	0.000395	0.00695	CbGpPWpGaD
Gefitinib—Diarrhoea—Glyburide—gestational diabetes	0.000383	0.0205	CcSEcCtD
Gefitinib—MKNK1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000378	0.00666	CbGpPWpGaD
Gefitinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000373	0.00657	CbGpPWpGaD
Gefitinib—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000368	0.00648	CbGpPWpGaD
Gefitinib—MAP2K5—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.00036	0.00635	CbGpPWpGaD
Gefitinib—ERBB3—PI-3K cascade—FGF2—gestational diabetes	0.000359	0.00633	CbGpPWpGaD
Gefitinib—ERBB3—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—gestational diabetes	0.000358	0.0063	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000357	0.00629	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000357	0.00628	CbGpPWpGaD
Gefitinib—Vomiting—Glyburide—gestational diabetes	0.000356	0.0191	CcSEcCtD
Gefitinib—Rash—Glyburide—gestational diabetes	0.000353	0.0189	CcSEcCtD
Gefitinib—Dermatitis—Glyburide—gestational diabetes	0.000353	0.0189	CcSEcCtD
Gefitinib—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000352	0.00621	CbGpPWpGaD
Gefitinib—ERBB3—PI3K/AKT activation—FGF2—gestational diabetes	0.000351	0.00618	CbGpPWpGaD
Gefitinib—CSNK1E—Circadian rythm related genes—LEP—gestational diabetes	0.00035	0.00616	CbGpPWpGaD
Gefitinib—ERBB3—GAB1 signalosome—FGF2—gestational diabetes	0.000348	0.00613	CbGpPWpGaD
Gefitinib—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000348	0.00612	CbGpPWpGaD
Gefitinib—ERBB3—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.00034	0.00599	CbGpPWpGaD
Gefitinib—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000337	0.00594	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—GCK—gestational diabetes	0.000335	0.00589	CbGpPWpGaD
Gefitinib—Nausea—Glyburide—gestational diabetes	0.000332	0.0178	CcSEcCtD
Gefitinib—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000328	0.00578	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000325	0.00573	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—ADIPOQ—gestational diabetes	0.000325	0.00572	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000323	0.00569	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—MBL2—gestational diabetes	0.000313	0.00551	CbGpPWpGaD
Gefitinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000302	0.00533	CbGpPWpGaD
Gefitinib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000288	0.00508	CbGpPWpGaD
Gefitinib—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000286	0.00503	CbGpPWpGaD
Gefitinib—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000285	0.00501	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000269	0.00473	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000266	0.00469	CbGpPWpGaD
Gefitinib—IRAK4—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000266	0.00468	CbGpPWpGaD
Gefitinib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000265	0.00467	CbGpPWpGaD
Gefitinib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000263	0.00463	CbGpPWpGaD
Gefitinib—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000262	0.00461	CbGpPWpGaD
Gefitinib—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000259	0.00457	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000259	0.00457	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000257	0.00453	CbGpPWpGaD
Gefitinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.000257	0.00453	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—FGF2—gestational diabetes	0.000253	0.00446	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—MBL2—gestational diabetes	0.000249	0.00439	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signal transduction—FGF2—gestational diabetes	0.000242	0.00426	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR—FGF2—gestational diabetes	0.00024	0.00424	CbGpPWpGaD
Gefitinib—MKNK1—MAPK Signaling Pathway—TNF—gestational diabetes	0.00024	0.00423	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB2—FGF2—gestational diabetes	0.000239	0.00421	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—FGF2—gestational diabetes	0.000238	0.00419	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000235	0.00413	CbGpPWpGaD
Gefitinib—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000234	0.00412	CbGpPWpGaD
Gefitinib—MKNK1—Disease—RBP4—gestational diabetes	0.000228	0.00402	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—LEP—gestational diabetes	0.000227	0.004	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000224	0.00395	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000224	0.00395	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—FGF2—gestational diabetes	0.000224	0.00395	CbGpPWpGaD
Gefitinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000223	0.00393	CbGpPWpGaD
Gefitinib—EGFR—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000223	0.00393	CbGpPWpGaD
Gefitinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—FGF2—gestational diabetes	0.000222	0.00391	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—FGF2—gestational diabetes	0.000222	0.00391	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.00022	0.00388	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—FGF2—gestational diabetes	0.000219	0.00386	CbGpPWpGaD
Gefitinib—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000215	0.00379	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000215	0.00378	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000215	0.00378	CbGpPWpGaD
Gefitinib—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000214	0.00378	CbGpPWpGaD
Gefitinib—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000213	0.00375	CbGpPWpGaD
Gefitinib—IRAK4—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000208	0.00366	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—MBL2—gestational diabetes	0.000208	0.00366	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—LEPR—gestational diabetes	0.000207	0.00365	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—FGF2—gestational diabetes	0.000207	0.00365	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000206	0.00363	CbGpPWpGaD
Gefitinib—MKNK1—Disease—NAMPT—gestational diabetes	0.000205	0.0036	CbGpPWpGaD
Gefitinib—MKNK1—Disease—GCK—gestational diabetes	0.000203	0.00358	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—LEP—gestational diabetes	0.000202	0.00356	CbGpPWpGaD
Gefitinib—EGFR—PI-3K cascade—FGF2—gestational diabetes	0.0002	0.00352	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000198	0.00349	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000197	0.00346	CbGpPWpGaD
Gefitinib—EGFR—PI3K/AKT activation—FGF2—gestational diabetes	0.000195	0.00344	CbGpPWpGaD
Gefitinib—EGFR—GAB1 signalosome—FGF2—gestational diabetes	0.000194	0.00341	CbGpPWpGaD
Gefitinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—FGF2—gestational diabetes	0.000189	0.00334	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000182	0.00321	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—MBL2—gestational diabetes	0.000182	0.00321	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—RBP4—gestational diabetes	0.000177	0.00312	CbGpPWpGaD
Gefitinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000177	0.00311	CbGpPWpGaD
Gefitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000173	0.00305	CbGpPWpGaD
Gefitinib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000171	0.00301	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000164	0.00289	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—LEPR—gestational diabetes	0.000161	0.00284	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.000161	0.00283	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—RBP4—gestational diabetes	0.00016	0.00281	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NAMPT—gestational diabetes	0.000159	0.0028	CbGpPWpGaD
Gefitinib—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000158	0.00279	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—FGF2—gestational diabetes	0.000158	0.00279	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—GCK—gestational diabetes	0.000158	0.00278	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—FGF2—gestational diabetes	0.000153	0.0027	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—FGF2—gestational diabetes	0.000153	0.00269	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000152	0.00267	CbGpPWpGaD
Gefitinib—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00015	0.00264	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—FGF2—gestational diabetes	0.00015	0.00263	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—TNF—gestational diabetes	0.000148	0.0026	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—MBL2—gestational diabetes	0.000145	0.00256	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000143	0.00252	CbGpPWpGaD
Gefitinib—EGFR—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000143	0.00252	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—GCK—gestational diabetes	0.000141	0.00249	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000141	0.00248	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000141	0.00248	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—FGF2—gestational diabetes	0.000141	0.00248	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000141	0.00248	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—MBL2—gestational diabetes	0.000139	0.00244	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000138	0.00243	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000136	0.00239	CbGpPWpGaD
Gefitinib—ERBB3—Disease—RBP4—gestational diabetes	0.000135	0.00238	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—FGF2—gestational diabetes	0.000135	0.00237	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—FGF2—gestational diabetes	0.000134	0.00236	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—FGF2—gestational diabetes	0.000133	0.00235	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—FGF2—gestational diabetes	0.000133	0.00233	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000131	0.0023	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—LEPR—gestational diabetes	0.000127	0.00224	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MTNR1B—gestational diabetes	0.000127	0.00224	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—FGF2—gestational diabetes	0.000127	0.00224	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000125	0.0022	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000125	0.0022	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—FGF2—gestational diabetes	0.000125	0.0022	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RBP4—gestational diabetes	0.000124	0.00219	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000124	0.00219	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—FGF2—gestational diabetes	0.000124	0.00218	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—LEPR—gestational diabetes	0.000123	0.00216	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000122	0.00216	CbGpPWpGaD
Gefitinib—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000122	0.00216	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—FGF2—gestational diabetes	0.000122	0.00215	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NAMPT—gestational diabetes	0.000121	0.00214	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—MBL2—gestational diabetes	0.000121	0.00213	CbGpPWpGaD
Gefitinib—ERBB3—Disease—GCK—gestational diabetes	0.00012	0.00212	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000118	0.00209	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000117	0.00207	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—ADIPOQ—gestational diabetes	0.000116	0.00205	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—FGF2—gestational diabetes	0.000115	0.00203	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000114	0.00201	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000113	0.00199	CbGpPWpGaD
Gefitinib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000113	0.00198	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000112	0.00197	CbGpPWpGaD
Gefitinib—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000112	0.00197	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.00011	0.00195	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GGCT—gestational diabetes	0.00011	0.00194	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—FGF2—gestational diabetes	0.000109	0.00192	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000108	0.00191	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TNF—gestational diabetes	0.000105	0.00185	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LEPR—gestational diabetes	0.000102	0.0018	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MTNR1B—gestational diabetes	0.000101	0.00177	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	9.82e-05	0.00173	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MTNR1B—gestational diabetes	9.71e-05	0.00171	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TNF—gestational diabetes	9.63e-05	0.0017	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GLS2—gestational diabetes	9.63e-05	0.0017	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RBP4—gestational diabetes	9.46e-05	0.00167	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—TNF—gestational diabetes	9.34e-05	0.00164	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—MTNR1B—gestational diabetes	9.15e-05	0.00161	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—FGF2—gestational diabetes	8.7e-05	0.00153	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—FGF2—gestational diabetes	8.5e-05	0.0015	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—FGF2—gestational diabetes	8.36e-05	0.00147	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MTNR1B—gestational diabetes	8.09e-05	0.00142	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MBL2—gestational diabetes	8.08e-05	0.00142	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TNF—gestational diabetes	7.92e-05	0.00139	CbGpPWpGaD
Gefitinib—MKNK1—Disease—FGF2—gestational diabetes	7.9e-05	0.00139	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GGCT—gestational diabetes	7.89e-05	0.00139	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RBP4—gestational diabetes	7.88e-05	0.00139	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	7.65e-05	0.00135	CbGpPWpGaD
Gefitinib—EGFR—Disease—RBP4—gestational diabetes	7.52e-05	0.00133	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	7.47e-05	0.00132	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGCT—gestational diabetes	7.46e-05	0.00131	CbGpPWpGaD
Gefitinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	7.36e-05	0.0013	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	7.31e-05	0.00129	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—LEP—gestational diabetes	7.28e-05	0.00128	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—FGF2—gestational diabetes	7.25e-05	0.00128	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—LEP—gestational diabetes	7.22e-05	0.00127	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.15e-05	0.00126	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	6.91e-05	0.00122	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GLS2—gestational diabetes	6.9e-05	0.00122	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEPR—gestational diabetes	6.84e-05	0.0012	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGCT—gestational diabetes	6.8e-05	0.0012	CbGpPWpGaD
Gefitinib—EGFR—Disease—NAMPT—gestational diabetes	6.75e-05	0.00119	CbGpPWpGaD
Gefitinib—EGFR—Disease—GCK—gestational diabetes	6.71e-05	0.00118	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GLS2—gestational diabetes	6.52e-05	0.00115	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—FGF2—gestational diabetes	6.36e-05	0.00112	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—FGF2—gestational diabetes	6.14e-05	0.00108	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGCT—gestational diabetes	6.1e-05	0.00107	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.05e-05	0.00107	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGCT—gestational diabetes	5.96e-05	0.00105	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GLS2—gestational diabetes	5.94e-05	0.00105	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.92e-05	0.00104	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.83e-05	0.00103	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—LEP—gestational diabetes	5.66e-05	0.000997	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGCT—gestational diabetes	5.61e-05	0.000989	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGCT—gestational diabetes	5.56e-05	0.00098	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—FGF2—gestational diabetes	5.53e-05	0.000974	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—FGF2—gestational diabetes	5.49e-05	0.000966	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MTNR1B—gestational diabetes	5.41e-05	0.000952	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GLS2—gestational diabetes	5.33e-05	0.00094	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.31e-05	0.000936	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NAMPT—gestational diabetes	5.28e-05	0.000929	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RBP4—gestational diabetes	5.27e-05	0.000928	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GCK—gestational diabetes	5.24e-05	0.000923	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GLS2—gestational diabetes	5.21e-05	0.000917	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—FGF2—gestational diabetes	5.07e-05	0.000893	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GLS2—gestational diabetes	4.91e-05	0.000864	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GLS2—gestational diabetes	4.86e-05	0.000857	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—FGF2—gestational diabetes	4.85e-05	0.000853	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.77e-05	0.00084	CbGpPWpGaD
Gefitinib—ERBB3—Disease—FGF2—gestational diabetes	4.68e-05	0.000824	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—FGF2—gestational diabetes	4.65e-05	0.00082	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	4.48e-05	0.000788	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.35e-05	0.000766	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—LEP—gestational diabetes	4.31e-05	0.00076	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—FGF2—gestational diabetes	4.3e-05	0.000758	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—FGF2—gestational diabetes	4.22e-05	0.000743	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CYP19A1—gestational diabetes	3.83e-05	0.000675	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NAMPT—gestational diabetes	3.78e-05	0.000666	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GCK—gestational diabetes	3.76e-05	0.000662	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGCT—gestational diabetes	3.67e-05	0.000646	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.61e-05	0.000635	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—LEP—gestational diabetes	3.59e-05	0.000633	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NAMPT—gestational diabetes	3.57e-05	0.000629	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GCK—gestational diabetes	3.55e-05	0.000625	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	3.4e-05	0.000599	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—gestational diabetes	3.34e-05	0.000588	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—FGF2—gestational diabetes	3.28e-05	0.000577	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NAMPT—gestational diabetes	3.26e-05	0.000573	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GCK—gestational diabetes	3.24e-05	0.00057	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.21e-05	0.000565	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NAMPT—gestational diabetes	2.92e-05	0.000515	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GCK—gestational diabetes	2.9e-05	0.000512	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NAMPT—gestational diabetes	2.85e-05	0.000502	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GCK—gestational diabetes	2.83e-05	0.000499	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FGF2—gestational diabetes	2.82e-05	0.000497	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	2.75e-05	0.000484	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—FGF2—gestational diabetes	2.73e-05	0.000481	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NAMPT—gestational diabetes	2.69e-05	0.000473	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GCK—gestational diabetes	2.67e-05	0.00047	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NAMPT—gestational diabetes	2.66e-05	0.000469	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GCK—gestational diabetes	2.65e-05	0.000466	CbGpPWpGaD
Gefitinib—EGFR—Disease—FGF2—gestational diabetes	2.61e-05	0.000459	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CYP19A1—gestational diabetes	2.59e-05	0.000457	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEP—gestational diabetes	2.4e-05	0.000423	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP19A1—gestational diabetes	2.37e-05	0.000417	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP19A1—gestational diabetes	2.12e-05	0.000374	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.07e-05	0.000365	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.95e-05	0.000344	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.94e-05	0.000341	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—FGF2—gestational diabetes	1.82e-05	0.000321	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.76e-05	0.00031	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GCK—gestational diabetes	1.75e-05	0.000308	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.28e-05	0.000225	CbGpPWpGaD
